Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor). While the manuscript is undergoing the peer review phase, the authors will not submit the manuscript to another journal without notifying the editor.
- The submission file is in Microsoft Word, RTF, or Open Office document file format.
- Where available, URLs for the references should be provided.
- The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
- The authors assure copyright of their article to the Institute of Hematology, Catholic University.
- Authors have declared any possible conflict of interest.
- Authors declare their availability to pay charges for publication when the paper was accepted. Invited authors of review-articles are excluded from any payment. Authors from low-income countries can request to the Editor in Chief a reduction of the publication charges.
To submit a new paper to our journal:
- Register on the Journal website;
- Follow the Guidelines for Authors;
- Read our Editorial Policies and our Competing Interest policies.
- Log in;
- Click on the "MAKE A SUBMISSION" button to start the online procedure.
To submit a revised version:
- Log in;
- Click on the title of your paper;
- Next to the heading "REVISIONS," upload your revised paper by using the "UPLOAD FILE" button;
- Inform the Editors that a revised version has been uploaded.
MJHID publishes reviews and original articles related to the diagnosis, management, and research of hematologic and infectious diseases. The Editors determine the content of the MJHID. MJHID does not require any fee for reviewing and online publication. MJHID, the Publisher, and the Editors of its publications assume no responsibility for the statements expressed by the contributors (and/or authors) of the articles. The manuscript submitted to the journal must not contain previously published material or material under consideration for publication elsewhere. Accepted manuscripts become the property of MJHID and may not be republished. All manuscripts will undergo peer review. An MJHID Editor will then make a final report and a subsequent decision about publication. If the Editor requires revision of the article, authors must send the correct version within three months; after three months, the item will be archived unless the authors apply for an extension.
Responsibilities of the Authors
By submitting a manuscript for publication, each author acknowledges having made a substantial contribution to:
- The conception and design of the study.
- The analysis and interpretation of the results.
- The writing of the paper.
And has approved the final submitted version of the manuscript. Thus, each author acknowledges responsibility for the integrity of the document, assures its originality, and guarantees that duplicate or redundant publications or submissions have not occurred. The Editors reserve the right to request the original data obtained in the investigation. Authors should declare any possible conflict of interest. Authors are responsible for all statements in the text. Experiments on humans should be made according to Helsinki Declaration 2008, http://science.education.nih.gov/supplements/nih9/bioethics/guide/teacher/Mod5_Helsinki.pdf or after approval of the local ethical committee. Experiments on animals should respect the "Animal Welfare Act" http://www.neavs.org/research/laws. Published Conflict-of-Interest Statements, Statements of Informed Consent, and Human and Animal Rights should be made according to the International Committee of Journal Medical Editors http://www.icmje.org/
These instructions are based in part on recommendations in the Uniform Requirements for Manuscripts Submitted to Biomedical Journal [Ann. Intern. Med. 1997; 126: 36-47]. Variations from guidelines in this publication reflect the individual style of MJHID. The authors should submit the manuscript as a complete file. Download an electronic version of the text (as an MS Word document) and unlabeled and labeled images (as JPEG files). The manuscript should be typed in Times New Roman font, double-spaced throughout on one side of the A4/Letter paper, with at least a 1.5 cm/ margin on all sides. Number all pages consecutively, beginning with the title page. Restrictions on page counts or the number of figures/videos are related to the type of submissions.
Organize the manuscript as follows: title page, abstract, introduction, material and methods, results, and a discussion including a conclusion, acknowledgments, references, figure legends, and tables. Keep acronyms and abbreviations to a minimum. When an abbreviation is used, define it at first mention and follow with the acronym in parentheses. All the manuscripts can be written both in American and British English. The inappropriateness of the language will not be considered a sufficient reason to reject the article. However, it is recommended that you get the English language checked by an expert.
Enago Inglese Editing Services
Enago offers Inglese language polishing services for scientific research papers for journal publication. Enago subject has expert editors (PhDs and Masters) with an average of 19 years of editing experience. Other than Inglese editing, they offer all levels of publication to support authors, including revised rejected editing, journal selection, artwork editing, word count reduction, and cover letter editing. An ISO 9001: 2008 certified company, Enago, is very careful about the quality delivered to authors. Exclusive regional websites and Enago services are listed below. Each of the websites Has localized payment options and invoices available on demand.
For Global researchers: Enago Global (http://www.enago.com). For Japanese researchers: Enago Japan. For Chinese researchers: Enago China. For Taiwanese researchers: Enago Taiwan. For Korean researchers: Enago Korea. For German researchers: Enago Germany. For Turkish researchers: Enago Turkey. For Portuguese researchers: Enago Brazil.
Categories of Submission
The review articles are solicited by the Editor in Chief or by the Guest Editors to authoritative investigators. Experts in the field, authors of publications in peer-reviewed journals, also not-solicited, can submit their manuscripts; however, the authors are invited to communicate before the topic and send a summary of their manuscript to obtain the approval of the Editor in Chief. The author(s) is free to design the paper. No particular format is required for these articles. Moreover, authors should consider the suggestions of PRISMA Group, Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647. doi: 10.1136/bmj.g7647. http://www.bmj.com/content/349/bmj.g7647.long
However, they should have an informative, unstructured abstract of about 250 words; we suggest limiting it to 10-12 pages (5-6000 words references). Mini-reviews (<4000 words and <100 references) will also be considered. References, figures, and legends follow the guidelines described below under Original Articles.
The following information should appear: the title of the article, authors' name and last name, affiliations, grant support, and presentation in part or whole at any meeting. Please identify the corresponding author and provide a full mailing address, phone and fax numbers, and e-mail address.
Provide an abstract of not more than 250 words. It should contain four paragraphs labeled Background, Objectives, Methods, Results, and Conclusions. They should briefly describe 1)How the problem is being addressed in the study, 2)how the study was performed, 3)the remarkable results, and 4) what the authors conclude from the results. No references should be cited. Introduction. Include brief background information on what has been done in the past in this area and the importance of your investigation. End with a statement of the purpose or hypothesis of the study.
Material and Methods.
This section may be divided into subsections if it facilitates reading the paper. The research design, subjects, material used, and statistical methods should be included. Do not mix results and discussion into this section. Do not include manufacturers' names unless the specific product is essential to the procedures performed, in which case the manufacturer's city, state, or country should also be given. Indicate that informed consent has been obtained from patients who participated in clinical investigations. In animal experimentation, acknowledge that ethical guidelines were followed. When appropriate, indicate that approval was obtained from the institution's review board.
This section may be divided into subsections if it facilitates reading the paper. All results based on methods must be included. If tables and graphic material will ease the understanding of the results, have them. Cite figures to illustrate the findings of the study.
Start with limited background information and then discuss the investigation results in light of what has been published in the past, the limitations of your study, and potential directions for future research. Inappropriate places, cite figures and graphs. A conclusion should summarize the study's major findings and their clinical usefulness.
Acknowledgments should appear on a separate page.
This section must be single-spaced and begin on a separate sheet. References are numbered consecutively in the order they appear in the text. All references must be cited in the text, with numbers enclosed in [square brackets] in line with the text (not superscript). The text should also cite papers submitted but not yet accepted for publication. Inclusive page numbers (e.g., 491-492) must be provided for all references. According to MeSH, journal names should be abbreviated. All authors should be listed in the references.
Style and punctuation of references
Journal article. [Reference number] Marcucci G, Radmacher MD, Maharry K, Mrózek K, Ruppert AS, Paschka P, Vukosavljevic T, Whitman SP, Baldus CD, Langer C, Liu CG, Carroll AJ, Powell BL, Garzon R, Croce CM, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358:1919-28
Journal online article. [Reference number]Stoddart A, McNerney ME, Bartom E, Bergerson R, Young DJ, Qian Z, Wang J, Fernald AA, Davis EM, Larson RA, White KP, Le Beau MM. Genetic pathways leading to therapy-related myeloid neoplasms. Mediterr J Hematol Infect Dis. 2011;3:e2011019. Epub 2011 May 16.
Book. [Reference number] Noback CR, Demarest RJ. The Human Nervous System. 2nd Ed., New York, McGraw-Hill. 1975; 199-201.
Edited book. [Reference number] Wyngaarden JB. Principles of human genetics. In: Wyngaarden JB, Smith LH, eds. Cecil Textbook of Medicine. 18th Ed., Philadelphia, W. B. Saunders Company. 1988; 146-152. URL (Web Page). [Reference number] Pantanowitz L, Früh K, Marconi S, Moses AV, Dezube BJ.
Pathology of rituximab-induced Kaposi sarcoma flare. http://www.biomedcentral.com/1472-6890/8/7 (published July 23, 2008).
Format: Author, if available. The title of the page is listed on the site—address of page (date accessed).
Each table should be given on a separate page. Each table has a short, descriptive title. Tables are numbered in the order cited in the text. Abbreviations are defined as footnotes at the bottom of each table. Tables should not duplicate data given in the text or figures.
Figures and Legends
The complete sets of original figures must be submitted. Legends should be in the present tense (e.g., 'Illustration shows ...'). Subjects' names must not appear on the figures. Labels should contrast well with the background. Images should be uniform in size and magnification. Illustrations should be free of all identifying information relative to the subject and institution. Line drawings should be professional in quality. Written permission to use all previously published illustrations must be included with the submission, and the source should be referenced in the legends. Written consent from any person recognizable in a photo is required. Legends must be double-spaced, and figures must be numbered in the order cited in the text. Label all pertinent findings.
Important new findings can be published in a format that fits a letter. Start the letter with a paragraph summarizing the rationale for the study and the major conclusions. The initial statement of this paragraph will be utilized as an abstract and headlines. Scientific Letters have a maximum of 2000 words in the text (excluding title, affiliations, figures, legends, or references), a maximum of 3 tables and/or figures, and only 20 essential references. Letters will appear in the table of contents, have a DOI, and be indexed in PubMed.
They will be considered only when they significantly expand the field of general medical knowledge and the knowledge of the disease's pathophysiology. The rarity of the case is not regarded as a criterion of priority. To speed up the publication, we suggest submitting the Clinical Cases of not more than three pages as letters to the Editor. To improve the educational support for our readers, we also advise submitting the Clinical Cases with a literature review as review articles.
Case Reports are considered full papers. Therefore, clinical cases will be published in the format of a Case Report only when they they report absolute novelties in explaining the pathophysiology of a disease or unknown mechanisms of a drug. Usually, it describes one to three patients or a single family. The text is limited to 2000 words, a maximum of 3 tables and figures (total), and up to 20 references. They begin with a brief summary of no more than 150 words. Clinical Cases with a literature review should be submitted as review articles and follow the recommendations of the Review Articles.
Educational Clinical Cases
When with a puzzling diagnosis at presentation and having a strong educational character, clinical cases will be assigned to the section MJHID Educational Clinical Cases. This section contains case studies of particular diagnostic difficulties and therapeutic interests. The diagnostic procedure should be represented step by step. The iconography must be complete and original. The diagnostic tool should be updated or adapted to local conditions. Differential diagnosis should be an important point to consider. Pages number and references are at the discretion of the authors (in general, not more than 3000 words and 30 references). They begin with a brief summary of the patient's data at presentation. Please send a presubmission inquiry to the Editorial Office at email@example.com to obtain approval for educational and clinical cases from the editor-in-chief. An example of an Educational Clinical Case can be viewed by clicking on it.
Letters to the Editor
Letters to the Editor may be used in primis to comment on articles that appeared in MJHID and give opinions about topics recently treated in the MJHID. Letters should be no more than three pages and submitted with a brief title. A maximum of 8-12 references may be included. Letters are published at the journal's discretion and are subject to editing. Case reports can be submitted as a letter to the Editor, possibly when referring to articles published in MJHID. The number of authors should not be more than six.
Books for Review
Publishers and authors who wish to have their titles considered for review should send review copies. Unsolicited book reviews are not considered. The submission file is in Microsoft Word, RTF, or WordPerfect document file format.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.